VAKALYUK, I. I.; VIRSTYUK, N. G. Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease. Current issues in pharmacy and medicine: science and practice, [S. l.], n. 1, 2018. DOI: 10.14739/2409-2932.2018.1.123648. Disponível em: http://pharmed.zsmu.edu.ua/article/view/123648. Acesso em: 6 oct. 2024.